Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE23554
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM577823
GPL96
Ovarian Cancer - Sample D1462 advanced-stage serous epithelial OVCAs overall survival in days: 313 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577824
GPL96
Ovarian Cancer - Sample D1858 advanced-stage serous epithelial OVCAs overall survival in days: 760 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: S grade: 2 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577825
GPL96
Ovarian Cancer - Sample D2147 advanced-stage serous epithelial OVCAs overall survival in days: 540 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577826
GPL96
Ovarian Cancer - Sample D2159 advanced-stage serous epithelial OVCAs overall survival in days: 3268 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577827
GPL96
Ovarian Cancer - Sample D2171 advanced-stage serous epithelial OVCAs overall survival in days: 5765 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577828
GPL96
Ovarian Cancer - Sample D2247 advanced-stage serous epithelial OVCAs overall survival in days: 3399 vital status: Dead cisplatin response (complete response or incomplete response): CR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577829
GPL96
Ovarian Cancer - Sample D2251 advanced-stage serous epithelial OVCAs overall survival in days: 1153 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577830
GPL96
Ovarian Cancer - Sample D2287 advanced-stage serous epithelial OVCAs overall survival in days: 184 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: S grade: 2 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577831
GPL96
Ovarian Cancer - Sample D2443 advanced-stage serous epithelial OVCAs overall survival in days: 73 vital status: Alive cisplatin response (complete response or incomplete response): IR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577832
GPL96
Ovarian Cancer - Sample D2457 advanced-stage serous epithelial OVCAs overall survival in days: 151 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577833
GPL96
Ovarian Cancer - Sample D2528 advanced-stage serous epithelial OVCAs overall survival in days: 2276 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: O grade: 1 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577834
GPL96
Ovarian Cancer - Sample D2578 advanced-stage serous epithelial OVCAs overall survival in days: 177 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577835
GPL96
Ovarian Cancer - Sample D2612 advanced-stage serous epithelial OVCAs overall survival in days: 2420 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: O grade: 2 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577836
GPL96
Ovarian Cancer - Sample D2622 advanced-stage serous epithelial OVCAs overall survival in days: 252 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: S grade: 2 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577837
GPL96
Ovarian Cancer - Sample D2651 advanced-stage serous epithelial OVCAs overall survival in days: 391 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577838
GPL96
Ovarian Cancer - Sample D2679 advanced-stage serous epithelial OVCAs overall survival in days: 1398 vital status: Dead cisplatin response (complete response or incomplete response): CR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577839
GPL96
Ovarian Cancer - Sample D2711 advanced-stage serous epithelial OVCAs overall survival in days: 1207 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577840
GPL96
Ovarian Cancer - Sample D2732 advanced-stage serous epithelial OVCAs overall survival in days: 1594 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577841
GPL96
Ovarian Cancer - Sample D2734 advanced-stage serous epithelial OVCAs overall survival in days: 2163 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: O grade: 2 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577842
GPL96
Ovarian Cancer - Sample D2736 advanced-stage serous epithelial OVCAs overall survival in days: 934 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577843
GPL96
Ovarian Cancer - Sample D2775 advanced-stage serous epithelial OVCAs overall survival in days: 1979 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: O grade: 2 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577844
GPL96
Ovarian Cancer - Sample D2791 advanced-stage serous epithelial OVCAs overall survival in days: 1588 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577845
GPL96
Ovarian Cancer - Sample M1777 advanced-stage serous epithelial OVCAs overall survival in days: 4288 vital status: Alive cisplatin response (complete response or incomplete response): CR debulking: S grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577846
GPL96
Ovarian Cancer - Sample M2241 advanced-stage serous epithelial OVCAs overall survival in days: 399 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577847
GPL96
Ovarian Cancer - Sample M3035 advanced-stage serous epithelial OVCAs overall survival in days: 852 vital status: Dead cisplatin response (complete response or incomplete response): CR debulking: S grade: 2 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577848
GPL96
Ovarian Cancer - Sample M3705 advanced-stage serous epithelial OVCAs overall survival in days: 1207 vital status: Dead cisplatin response (complete response or incomplete response): IR debulking: O grade: 3 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577849
GPL96
Ovarian Cancer - Sample M4171 advanced-stage serous epithelial OVCAs overall survival in days: 1598 vital status: Dead cisplatin response (complete response or incomplete response): CR debulking: S grade: 1 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
GSM577850
GPL96
Ovarian Cancer - Sample M897 advanced-stage serous epithelial OVCAs overall survival in days: 1123 vital status: Dead cisplatin response (complete response or incomplete response): CR debulking: NA grade: 2 Advanced-stage serous epithelial ovarian cancer resected at the time of primary surgery from patient who would receive platinum-based therapy.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes